Blood draw and questionnaires

OTHER2 trials

Sponsors

Memorial Sloan Kettering Cancer Center

Conditions

Breast CancerLung CancerSecond Primary Lung CancerSingle Primary Lung Cancer

Unknown Phase

DNA Repair and Genetic Susceptibility to Lung Cancer

CompletedNCT00611598

Memorial Sloan Kettering Cancer CenterLung Cancer, Second Primary Lung Cancer, Single Primary Lung Cancer

Start: 2003-02-11End: 2023-03-24Updated: 2023-03-29

Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations

RecruitingNCT00823654

Memorial Sloan Kettering Cancer CenterBreast Cancer

Start: 2009-01-31End: 2027-01-31Target: 609Updated: 2025-10-14

Related Papers

Impact of breast cancer chemotherapy on ovarian damage and recovery.

Journal of Clinical Oncology2020-05-202 citations

Increased chemotherapy-induced ovarian reserve loss in women with germline BRCA mutations due to oocyte deoxyribonucleic acid double strand break repair deficiency

Fertility and Sterility2020-04-2272 citations

Abstract PD6-06: Impact of <i>BRCA</i> mutations on chemotherapy-induced loss of ovarian reserve: A prospective longitudinal study

Cancer Research2019-02-152 citations